MTOR and hepatocellular carcinoma: As this signaling pathway is activated by CCL20 in hepatocellular carcinoma (HCC), it could be assumed that this occurs in melanoma cells as well, particularly CCL20 signals via the PI3K/AKT/mTOR pathway.